Alacrita LLP: Life Science and Pharmaceutical Consulting
Alacrita LLP is a transatlantic life science and pharmaceutical consulting firm headquartered in London, United Kingdom, having been founded in 2009. The entity is registered in England & Wales (No. OC345738) and operates from the London Bioscience Innovation Centre. Alacrita's core value proposition is to provide strategic expertise, specialized analysis, and hands-on execution support to help life science companies, investors, and academic institutions advance their research and development (R&D) and business objectives across every stage of the drug development lifecycle.
The firm is built on a model of leveraging real-world experience, utilizing a core team of partners and consultants who command a vast network of specialists often exceeding 350 proven experts???who have spent their careers discovering, developing, manufacturing, and commercializing drug products. This structure allows Alacrita to deliver the depth of expertise typically associated with a specialist consulting firm, but across a wide breadth of disciplines and therapeutic areas, offering both strategic guidance and practical, integrated execution support.
Services and Products Offered
Alacrita does not offer tangible products but provides a comprehensive suite of consulting and professional services that fall into distinct categories, all grounded in deep, functional expertise within the life sciences industry. The primary client base includes biotech and pharma organizations of all sizes, including start-ups, established multinational companies, healthcare investors (Venture Capital and Private Equity), and technology transfer offices at academic institutions.
I. Product Development Services
These services focus on the scientific and technical pathway from concept to regulatory approval and manufacturing. The goal is to maximize the value of an asset at each stage of its development.
Research & IP Evaluation: Providing strategic advice, intellectual property (IP) due diligence, freedom-to-operate analyses, and portfolio rationalization to establish a strong foundation for new assets.
Preclinical Strategy & Execution: Covering functional areas such as Toxicology, Preclinical and CMC (Chemistry, Manufacturing, and Controls) strategy, including advising on recombinant DNA products, conventional pharmaceuticals, and medical devices.
Clinical Development: Offering pharmaceutical physicians and clinical project managers who plan and implement clinical development programs for both small molecules and biologics, including biostatistics support.
Regulatory Affairs: A powerful practice providing auditing, regulatory strategy, due diligence, and preparation of technical files for CE marking for all types of medical devices and in vitro diagnostics (IVDs).
CMC Consulting: Specializing in Drug Delivery & Formulations (e.g., oral, topical, transdermal, parenteral products), Manufacturing & Quality, and Supply Chain Management, ensuring compliance with GLP, GMP, and GCP standards.
II. Enterprise Development Services
These offerings are designed to build the strategic and operational foundations necessary for emerging life science companies to advance and secure funding for their programs.
Business Plans & Fundraising Support: Orchestrating the strategic expertise required to transform biotech concepts into fundable realities, including building models to analyze market positioning and develop future cash flow forecasts.
Virtual Biotech / Interim CXO: Providing flexible, hands-on management support and operational continuity through key inflection points, often stepping in as interim executive officers (e.g., CSO, CMO, COO).
Technology Platform Strategy: Advising on the strategic positioning and advancement of core technology platforms within a company.
Pharmaceutical Launch Planning: Assisting in the preparation and execution of market access and commercialization strategies for new products.
III. Business Development Services
Alacrita helps clients identify, evaluate, and transact on new opportunities, often integrating directly with a company's in-house business development team.
Asset Scouting: Proactively identifying and evaluating new assets that align with a client's growth strategy.
Due Diligence: Comprehensive due diligence management for transactions, covering IP, regulatory, manufacturing, and clinical development aspects, including interviewing key opinion leaders.
Pharma & Biotech Valuations: Providing accurate and grounded valuations for assets, companies, and deals.
Partnering & Deal-making: Facilitating negotiations and transactions for in-licensing, out-licensing, and other strategic partnerships with big pharma and start-ups.
IV. Investor and Legal Services
The firm serves the investment community and legal sector by providing unbiased, expert insights.
Investor Services: Assisting life science investors (e.g., VC, PE) with technical and commercial due diligence prior to investment decisions.
Expert Witness: Consultants are available to assist legal teams in litigation, including preparing expert reports, providing valuations with respect to damages, and participating in hearings.
Industry and Functional Expertise
Alacrita's expertise spans a vast array of life science industry segments and functional areas, enabling it to address complex challenges in highly specialized niches:
Industry Segments: Small molecules, Antibodies & ADCs, Vaccines, Cell Therapies, Gene Therapy, Diagnostics, Medical Devices, Personalized Medicine, Radiopharmaceuticals, OTC Healthcare, and Nutrition.
Therapeutic Areas: Oncology, Autoimmune/Immunology, Cardiovascular, Central Nervous System (CNS), Orphan Diseases, Respiratory, Dermatology, and Digestive/GI, among others.
Functional Disciplines: In addition to the core services, the firm's network provides specialized support in areas like Biostatistics, Quality Assurance (QA), and specialized aspects of Drug Delivery, covering technical and strategic issues for both Novel Chemical Entities (NCEs) and biologics.
Please note: This information is generated by AI. For legal use, verify with company sources.
